Anlon Healthcare IPO opens on August 26; check price band, lot size, strengths, risks and key dayes

Anlon Healthcare IPO: Chemical manufacturer Anlon Healthcare will hit the primary market on August 26. The issue will conclude on August 29. The price band has been fixed at ₹86 to ₹91 per share.

The initial public offering seeks to raise ₹121.03 crore by offering 1.33 crore new equity shares. There is no offer for sale component.

The money raised will be used for capital expenditure requirements for proposed expansion, debt repayment, working capital needs and general corporate purposes.

Anlon Healthcare IPO lot size

An application size consists of one lot or 164 shares. The company has reserved 75% of the net issue for qualified institutional buyers, 15% for non-institutional investors and 10% for retail investors.

Anlon Healthcare IPO timeline: Allotment and listing dates

Interactive Financial Services is the issue's book-running lead manager, while KFin Technologies is the registrar.

Anlon Healthcare, a chemical manufacturing company, makes pharma intermediates and active pharmaceutical ingredients (APIs).

Anlon Healthcare IPO: Strengths

• Anlon Healthcare, in its red herring prospectus, said it has a strong product portfolio and scalable business. Its products are manufactured in accordance with pharmacopeia standards like IP, BP, EP, JP, and USP.
• The company maintains quality standards through rigorous quality checks and detailed analysis. It has four testing laboratories for adding new generic APIs, process optimisation and testing its products against the specified industry standards.
• It has strong promoters and an experienced management team, according to its RHP. The promoters have been associated with the firm since inception and have played a key role in shaping and developing business operations.

Anlon Healthcare: Risks

• It is subject to strict technical specifications, regular inspections, quality requirements and audits by customers and their representatives. Any failure to comply with these requirements can negatively impact its business, including cancellation of existing and future orders.
• Its top 10 customers contributed 75.71% to the company's revenue in the financial year 2023-24. Loss of any of these customers can impact business.
• It has experienced negative operating cash flows from operations for the period ended on January 31, 2025, and in FY24, FY23 and FY22.